Skip to main content

Table 2 Comparisons between HBsAg-seropositive and HBsAg-seronegative diabetic patients according to age and biochemical measurements

From: Molecular evaluation of hepatitis B virus infection and predominant mutations of pre-core, basal core promoter and S regions in an Iranian population with type 2 diabetes mellitus: a case–control study

 

Means ± SD of all diabetic participants (733)

Means ± SD of HBsAg negative subjects (705)

Means ± SD of anti- HBsAg positive subjects (28)

P-value

Age (year)

55.1937 ± 11.74690

55.0057 ± 11.65605

59.9286 ± 13.20474

0.03

FBS mg/dL

170.5730 ± 72.25192

171.1504 ± 72.59905

156.0357 ± 62.24770

0.28

Chol mg/dL

197.7640 ± 53.02186

198.3730 ± 53.09670

182.4286 ± 49.54566

0.12

TG mg/dL

192.2128 ± 86.48698

193.2610 ± 87.14868

165.8214 ± 63.32693

0.1

ALT IU/L

31.5375 ± 21.55816

31.2979 ± 21.29852

37.5714 ± 27.07114

0.13

AST IU/L

24.8554 ± 13.89916

24.7319 ± 13.90054

27.9643 ± 13.74498

0.23

  1. FBS fasting blood sugar; TG triglyceride; ALT alanine aminotransferase; AST aspartate aminotransferase; HBsAg hepatitis B surface antigen